SERUM PROCOLLAGEN TYPE I N-TERMINAL PROPEPTIDE DECREASED

This adverse event was reported 19 times

These drugs are most commonly taken by patients reporting SERUM PROCOLLAGEN TYPE I N-TERMINAL PROPEPTIDE DECREASED:

# Drug Count
0 DENOSUMAB 8
1 ABALOPARATIDE 6
2 ROMOSOZUMAB-AQQG 5
3 CALCIUM 4
4 ACALABRUTINIB 1
5 ANTACID 1
6 ASPIRIN 1
7 ASPIRIN 325 MG 1
8 ASPIRIN 81 MG 1
9 CALCIUM CARBONATE 1
See all common drugs associated with SERUM PROCOLLAGEN TYPE I N-TERMINAL PROPEPTIDE DECREASED

SERUM PROCOLLAGEN TYPE I N-TERMINAL PROPEPTIDE DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ROMOSOZUMAB-AQQG 5 0.0004
1 ABALOPARATIDE 6 0.0002
2 ACALABRUTINIB 1 0.0001
3 INDAPAMIDE 1 0.0001
4 DENOSUMAB 8 0.0000
5 ERGOCALCIFEROL 1 0.0000
6 CALCIUM CARBONATE 1 0.0000
7 ASPIRIN 1 0.0000
See all drugs enriched for association with SERUM PROCOLLAGEN TYPE I N-TERMINAL PROPEPTIDE DECREASED

SERUM PROCOLLAGEN TYPE I N-TERMINAL PROPEPTIDE DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Parathyroid Hormone-Related Peptide Analog [EPC] 6 0.0002
1 Provitamin D2 Compound [EPC] 3 0.0001
2 RANK Ligand Inhibitor [EPC] 8 0.0000
3 Calcium [EPC] 4 0.0000
4 Thiazide-like Diuretic [EPC] 1 0.0000
5 Kinase Inhibitor [EPC] 1 0.0000
6 Platelet Aggregation Inhibitor [EPC] 1 0.0000
7 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with SERUM PROCOLLAGEN TYPE I N-TERMINAL PROPEPTIDE DECREASED